1174727

Rachel A. Kuperman, M.D. — FEI 3022075123

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 27, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Piedmont, CA (United States)

Additional Details

Clinical Investigator (CI)